首页> 外国专利> MEDIA AND PROCESSES FOR THE EX VIVO PRODUCTION OF MEGAKARYOCYTES FROM HUMAN CD34+ CELLS

MEDIA AND PROCESSES FOR THE EX VIVO PRODUCTION OF MEGAKARYOCYTES FROM HUMAN CD34+ CELLS

机译:从人CD34 +细胞体外生产巨核细胞的培养基和过程

摘要

Disclosed herein are media and processes for the ex vivo production of megakaryocytes from human CD34+ cells, in which human CD34+ cells, either being freshly isolated from a newborn's cord blood or having been subcultured in an expansion medium after isolation from a newborn's cord blood, are subjected to cultivation in a cultivating medium consisting essentially of a basal medium, a serum substitute and a cytokine cocktail, wherein the serum substitute consists of human serum albumin, insulin, and transferrin; and the cytokine cocktail consists of thrombopoietin (TPO), stem cell factor (SCF), Flt-3 ligand (FL), interleukin-3 (IL-3), IL-6, IL-9, and granulocyte-macrophage colony-stimulating factor (GM-CSF).
机译:本文公开了从人CD34 + 细胞离体生产巨核细胞的培养基和方法,其中人CD34 + 细胞是从新生儿脐带血中新鲜分离得到的,或者是从人脐带血中分离得到的。在从新生儿脐带血中分离后在膨胀培养基中进行继代培养后,应在基本上由基础培养基,血清替代物和细胞因子混合物组成的培养基中进行培养,其中血清替代物由人血清白蛋白,胰岛素,和转铁蛋白;细胞因子混合物由血小板生成素(TPO),干细胞因子(SCF),Flt-3配体(FL),白介素3(IL-3),IL-6,IL-9和刺激粒细胞巨噬细胞集落组成因子(GM-CSF)。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号